Pernille Tine Jensen

Medicine & Life Sciences

1. Endometrial Neoplasms 100%
2. Uterine Cervical Neoplasms 96%
3. Robotics 61%
4. Patient Reported Outcome Measures 56%
5. Neoplasms 55%
6. Ovarian Neoplasms 37%
7. Quality of Life 37%
8. Minimally Invasive Surgical Procedures 33%
9. Recurrence 31%
10. Sentinel Lymph Node 27%
11. Hysterectomy 27%
12. Delivery of Health Care 25%
13. Musculoskeletal Pain 25%
14. Cancer Survivors 24%
15. Aftercare 24%
16. Self-Assessment 24%
17. Registries 22%
18. Systematic Reviews 22%
19. Surgeons 21%
20. Rehabilitation 20%
21. Lymphedema 19%
22. Laparoscopy 19%
23. Fallopian Tube Neoplasms 19%
24. Trachelectomy 19%
25. Denmark 17%
26. Positron Emission Tomography Computed Tomography 17%
27. Therapeutics 16%
28. Radiotherapy 16%
29. Organizations 16%
30. Longitudinal Studies 16%
31. Breast Neoplasms 15%
32. Cohort Studies 15%
33. Gynecology 13%
34. Neoplasm Metastasis 12%
35. Referral and Consultation 12%
36. Population 12%
37. Randomized Controlled Trials 11%
38. Survivorship 11%
39. Survival 11%
40. Costs and Cost Analysis 10%
41. Fallopian Tubes 10%
42. Fear 10%
43. Incidence 10%
44. Prospective Studies 9%
45. Ergonomics 9%
46. Vulvar Neoplasms 9%
47. Morbidity 9%
48. Perimenopause 9%
49. Lymph Nodes 8%
50. Epidemiology 8%